Home
Watchlist
News
Signals
Picks
DJI
+0.07%
SPX
+0.15%
IXIC
+0.48%
FTSE
+0.14%
N225
+1.45%
AXJO
-0.24%
Log In
Get Started
Home
Watchlist
News
Signals
Picks
Stocks
Add to Watchlist
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.
Company
About Us
Careers
Blog
News
Help & Support
Help Center
Contact Us
Pro Support
Legal
Privacy Policy
Terms of Use
Instagram
YouTube
© 2024 Cashu PTY LTD.
Join our newsletter to keep up to date with us!
Sign Up
Signals
SNDX
Syndax Pharmaceuticals
21 days ago
SNDX Dennis Podlesak sells $273K worth of shares
0.00%
📡️ Health Care
SNDX
Syndax Pharmaceuticals
21 days ago
SNDX Dennis Podlesak sells $298K worth of shares
0.00%
📡️ Health Care
SNDX
Syndax Pharmaceuticals
21 days ago
SNDX Dennis Podlesak sells $304K worth of shares
0.00%
📡️ Health Care
SNDX
Syndax Pharmaceuticals
about 1 month ago
Analysts think SNDX stock price could increase by 174%
36.84%
📡️ Health Care
SNDX
Syndax Pharmaceuticals
about 1 month ago
SNDX beat EPS expectations by 19.92%
0.00%
📡️ Health Care
SNDX
Syndax Pharmaceuticals
4 months ago
SNDX Nicholas AJ. Botwood buys $106K worth of shares
0.00%
📡️ Health Care
SNDX
Syndax Pharmaceuticals
4 months ago
SNDX Keith Katkin buys $91K worth of shares
0.00%
📡️ Health Care
SNDX
Syndax Pharmaceuticals
4 months ago
SNDX Martin H Huber JR. buys $45K worth of shares
0.00%
📡️ Health Care
SNDX
Syndax Pharmaceuticals
4 months ago
Analysts think SNDX stock price could increase by 243%
4.05%
📡️ Health Care
SNDX
Syndax Pharmaceuticals
4 months ago
SNDX beat EPS expectations by 27.80%
0.00%
📡️ Health Care
SNDX
Syndax Pharmaceuticals
5 months ago
Analysts think SNDX stock price could increase by 235%
-5.68%
📡️ Health Care
SNDX
Syndax Pharmaceuticals
6 months ago
SNDX missed EPS expectations by 370.69%
0.00%
📡️ Health Care
Stocks
Health Care
sndx
Add to Watchlist
Syndax Pharmaceuticals
NASDAQ: SNDX
-0.67 (-3.93%)
16.37
USD
At close at Sep 08, 18:41 UTC
Summary
News
Signals
Benchmarks
Financials